The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic implications of PD-L1 expression in breast cancer at the protein and mRNA levels.
 
Alexios Matikas
No Relationships to Disclose
 
Ioannis Zerdes
No Relationships to Disclose
 
John Lovrot
Employment - RaySearch Laboratories
 
François Richard
No Relationships to Disclose
 
Christos Sotiriou
Consulting or Advisory Role - Amgen; Astellas Pharma; Astellas Pharma; CEPHEID; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Foundation Medicine; Prime Oncology; Teva
Patents, Royalties, Other Intellectual Property - A companion diagnostic for CDK4/CDK6 inhibitory drugs based on CDK4 Phosphorylation. Which patient to be treated and how. PCT/EP2017/061780; Epigenetic portraits of human Breast Cancer, PCT/EP2012/050836, WO2012/098215
Travel, Accommodations, Expenses - Roche; Roche/Genentech; Roche/Genentech
 
Jonas C. S. Bergh
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - UpToDate
 
Antonios Valachis
No Relationships to Disclose
 
Theodoros Foukakis
Honoraria - UpToDate
Research Funding - Pfizer (Inst)